A new e-book aims to tackle the myths and misconceptions around cannabis and arm consumers with the all the science-backed knowledge they need.
Cannabis science firm, Global Cannabinoid Solutions (GCS) has announced the publication of its first consumer safety guide, The Canna-Manual.
Dubbed as a public education guide, the e-book brings together the latest scientific knowledge, education and peer-reviewed research to arm consumers with a ‘big picture perspective’ of cannabis.
Less than one percent of British patients have legal access to cannabis leaving cancer patients, veterans with PTSD and grandparents living with chronic pain, criminals in the eyes of the law.
Through The Canna-Manual, GCS aims to highlight the societal implications that current UK legislation brings, and raise awareness of the science behind the plant and its unique relationship with humanity.
Author and GCS’ managing director Chris Tasker, who holds a Masters (MRes) in Cannabis medical research has conducted first-hand research to explore the therapeutic effects of cannabinoids and the endocannabinoid system in colorectal cancer and inflammatory bowel disease.
He has supported the growth of informed cannabis debate across the UK, promoting cannabis education and drug law reform.
Alongside a team of scientists and consultants at GCS, he now works to steer early cannabis enterprise with their multidisciplinary understanding of cannabis and endocannabinoid medicine.
“Up until now, there has been a tremendous disconnect between science, industry, and society, resulting in an incoherent cannabis conversation,” writes Chris.
“This book aims to provide a reliable foundation of knowledge that helps readers understand the depth of the relationship between cannabis and humans.
“With this, we hope to protect readers from the common myths and misconceptions around cannabis and continue to prepare the public for a wider discussion around cannabis and our treatment of drugs as a whole.”
A percentage of the proceeds from The Canna-Manual will be allocated to supporting patient prescriptions costs and the community.
Chris commented: “This guide unifies world-leading cannabis knowledge and places it in the hands of consumers.
“This prepares readers for the emergence of the cannabis industry outlining the very real challenges impacting people on the frontline.”
GCS has also launched The Cannabis Crash Course e-book, an industry preparation guide to help professionals safely and effectively navigate the ever-changing cannabis sector.
The Canna-Manual and The Cannabis Crash Course are available on Amazon now.
- 3 main contributors to the entourage effect for cannabis consumers to consider
- Medical cannabis doesn’t impair cognitive function – study
- Ukraine’s medical cannabis legalisation delayed by opponents
- Cannabis more ‘advantageous’ than conventional sleep aids
- Four20 Medical Cannabis Products Launched in the UK via Rokshaw
- The potential of Medical Cannabis in diabetes management
- News4 months ago
NHS approves major clinical trial on cannabis medicines and chronic pain
- News6 months ago
UK patient secures first NHS reimbursement for cannabis flowers
- Advocacy6 months ago
Inside a UK cannabis club: changing lives, tackling stigma, building community
- News4 months ago
UK research finds GP support for cannabis as an alternative to opioids for chronic pain
- Industry4 months ago
‘Landmark’ ruling gives hope for UK CBD flower businesses
- Industry6 months ago
New report calls for overhaul of ‘discriminatory’ UK cannabis driving laws
- News4 months ago
Malta: Advocates emphasise positive effects of cannabis reform amid ‘normalisation’ concerns
- Science6 months ago
Medicinal cannabis ‘life-changing’ for Tourette syndrome – study